17-alpha-hydroxypregnenolone and HIV Coinfection

17-alpha-hydroxypregnenolone has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Blanche, S; Frange, P; Kariyawasam, D; Laborde, K; Parat, S; Polak, M; Simon, A; Souchon, PF	1

Other Studies

1 other study(ies) available for 17-alpha-hydroxypregnenolone and HIV Coinfection

Article	Year
Adrenal enzyme impairment in neonates and adolescents treated with ritonavir and protease inhibitors for HIV exposure or infection. Hormone research in paediatrics, 2014, Volume: 81, Issue:4 Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Anti-HIV Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; HIV Infections; Humans; Hydrocortisone; Infant, Newborn; Male; Protease Inhibitors; Ritonavir; Young Adult	2014

Article

Year

Adrenal enzyme impairment in neonates and adolescents treated with ritonavir and protease inhibitors for HIV exposure or infection.

Hormone research in paediatrics, 2014, Volume: 81, Issue:4

Topics: 17-alpha-Hydroxypregnenolone; 17-alpha-Hydroxyprogesterone; Adolescent; Adrenal Glands; Anti-HIV Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; HIV Infections; Humans; Hydrocortisone; Infant, Newborn; Male; Protease Inhibitors; Ritonavir; Young Adult

2014